Hiroto Terasaki
Overview
Explore the profile of Hiroto Terasaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagai N, Matsubara H, Terasaki H, Hirano T, Kato A, Miki A, et al.
Ophthalmol Sci
. 2025 Feb;
5(1):100612.
PMID: 39963552
Purpose: To evaluate the OCT images of eyes with fovea-involved complete retinal pigment epithelial and outer retinal atrophy (cRORA) as well as best-corrected visual acuity (BCVA) to explore the pathogenesis...
2.
Funatsu R, Terasaki H, Mihara N, Sonoda S, Shiihara H, Miyake S, et al.
Retina
. 2025 Jan;
PMID: 39841922
Purpose: To identify optical coherence tomography (OCT)-based imaging biomarkers that can localize focal leakage points without fluorescein angiography in central serous chorioretinopathy (CSC). Methods: This retrospective case-control study analyzed 119...
3.
Ishikawa H, Uchida K, Terasaki H, Sakamoto T, Kakinoki M, Ohji M, et al.
Sci Rep
. 2025 Jan;
15(1):811.
PMID: 39755919
This retrospective observational multicentre cohort study compared the rate of postoperative cystoid macular oedema (CME) between two intraocular lens (IOL) scleral fixation (SFIOL) techniques: a flanged IOL fixation technique (Yamane...
4.
Sugimoto M, Chujo S, Kato K, Shimura M, Kitano S, Kusuhara S, et al.
J Clin Med
. 2024 Dec;
13(23).
PMID: 39685795
: The object of this study was to determine the outcomes of treatments other than anti-vascular endothelial growth factor (VEGF) therapy for diabetic macular edema (DME) before and after the...
5.
Funatsu R, Terasaki H, Mihara N, Shiihara H, Sonoda S, Sakamoto T
Graefes Arch Clin Exp Ophthalmol
. 2024 Nov;
PMID: 39576354
Purpose: To comprehensively evaluate baseline characteristics of patients with central serous chorioretinopathy (CSC) and develop predictive risk scores to identify visual prognosis. Methods: This single-institute, retrospective cohort study included 144...
6.
Kominami A, Tomita S, Kato A, Ono K, Takeuchi M, Imazeki M, et al.
J Clin Med
. 2024 Oct;
13(20).
PMID: 39458195
: Anti-vascular endothelial growth factor (VEGF) therapy is the first-line treatment for neovascular age-related macular degeneration (nvAMD). While proactive and adequate treatment generally leads to better visual outcomes, various factors,...
7.
Sawazono A, Funatsu R, Terasaki H, Mihara N, Sakamoto T
Cureus
. 2024 Oct;
16(9):e69639.
PMID: 39429384
This study aimed to characterize the detailed multi-modal imaging findings of red blood cell (RBC)-coated intraocular lenses (IOLs). A 68-year-old patient with polypoidal choroidal vasculopathy underwent vitrectomy for subretinal and...
8.
Shimura M, Hirano T, Tsuiki E, Takamura Y, Morizane Y, Akiyama K, et al.
Retina
. 2024 Oct;
45(2):335-344.
PMID: 39423137
Purpose: To assess the real-world outcome of best-corrected visual acuity after 2-year intervention for treatment-naive diabetic macular edema since the approval of anti-vascular endothelial growth factor therapy. Methods: A total...
9.
Terasaki H, Sakamoto T
Ophthalmic Surg Lasers Imaging Retina
. 2024 Sep;
56(1):57-59.
PMID: 39231112
Background And Objective: Rhegmatogenous retinal detachment (RRD) of the posterior pole accounted for only 3.5% of all RRD cases in Japan, with most being macular hole retinal detachments, which are...
10.
Yamashita T, Asaoka R, Iwase A, Sakai H, Terasaki H, Sakamoto T, et al.
Jpn J Ophthalmol
. 2024 Jul;
68(5):586-593.
PMID: 39083146
Purpose: To investigate the relationship between the fundus sex index obtained from fundus photographs and body height or axial length in the Kumejima population. Study Design: Prospective cross-sectional observational population...